Explore clinical cases in breast cancer presented by the experts. These downloadable slides presented at the 6th Annual PLATO Fellows Forum in Breast Oncology in Chicago show real cases seen in the clinic and provide supporting information on the reasoning behind the clinical choices made by the experts.
Jun 8, 2017
Jun 8, 2018
- Jennifer Caswell-Jin, MD, Stanford University, Palo Alto, California, United States
- Mark Pegram, MD, Stanford Comprehensive Cancer Institute, Stanford University School of Medicine, Palo Alto, California, United States
Case #1—Neoadjuvant therapy for HER2-positive breast cancer
- Tom Degenhardt, MD, University of Munich, Munich, Germany
- Nadia Harbeck, MD, PhD, University of Munich, Munich, Germany
Case #2—Targeting cyclin-dependent kinases (CDK) 4/6 in breast cancer management
- Tomohiro Nishijima, MD, University of North Carolina, Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States
- Hyman B. Muss, MD, University of North Carolina, Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States
Case #3—Breast cancer in the older patient
- Carlos Arteaga, MD, Vanderbilt University, Nashville, Tennessee, United States
- Katy Eby Beckermann, MD, PhD, Vanderbilt University, Nashville, Tennessee, United States
Case #4—How do we integrate precision medicine into the standard of care for breast cancer?
This educational activity is specifically designed for physicians in training in medical oncology who are interested in breast cancer.
After successful completion of this educational activity, participants should be able to:
- Assess the current status of treatment for breast cancer, including recent advances and areas of unmet need
- Examine current data regarding emerging treatment strategies for the management of breast cancer
This educational activity is supported by a grant from the Breast Cancer Research Foundation.
Enduring Materials From a Certified Activity
This enduring material, derived from a certified live event, contains content that is evidence-based, balanced, and free of commercial bias. While the content was planned and implemented by prIME Oncology for a certified live event, this activity does not offer continuing education credit.
This activity is jointly provided by prIME Oncology and the PLATO Foundation.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Disclosure Regarding Unlabeled Use
This activity may contain discussion of published and/or investigational uses of agents that are not indicated by the US Food and Drug Administration or European Medicines Agency. Please refer to the official prescribing information for each product discussed for discussions of approved indications, contraindications, and warnings.